American Well Corp, known as Amwell, is a leading telemedicine company headquartered in Boston, Massachusetts. The company is publicly traded, with the ticker symbol AMWL, and its primary objective is to connect and enable providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality healthcare. Amwell believes that digital care delivery will transform healthcare and aims to act as the connective tissue for thousands of healthcare providers across the country.
Founded in 2006 by Drs. Ido and Roy Schoenberg, Amwell harnesses mobile technology to bring telemedicine to the masses. The company has grown rapidly over the past decade, buoyed by increasing demand for affordable and accessible healthcare solutions. As of now, it's one of the biggest players in the digital health space with an extensive network of care providers and health systems.
With Amwell’s web or mobile platform, patients can have live video visits with a board-certified doctor of their choice in just minutes. Doctors and specialists are available all day and night, every day of the year. The company extends these services to acute care, home health, and even specialty care consultations, integrating with leading EHR and health system platforms along the way.
Amwell's patient-centric approach and innovative technology have captured the interest of global investors. In 2020, the company underwent a successful initial public offering (IPO) that helped it raise more substantial funds to support its operations and growth plans.
Despite gaining a competitive edge in the telehealth market, Amwell continues to invest in technological enhancements. They feature an AI-powered interface, designed to streamline and enhance the telehealth experience for both physicians and patients. Their technology solutions incorporate real-time patient data collection, augmented reality, clinical decision support, and even integrations for connected medical devices.
As the healthcare space continues its shift to digitization, particularly post-COVID-19, companies like Amwell stand to benefit from increased demand for remote health services. The company’s robust platform, coupled with its commitment to innovation and improving patient outcomes, positions Amwell as a formidable force in the field of telehealth and digital health delivery. As more healthcare providers adopt telemedicine solutions, AMWL is ideally placed to secure a significant market share in this growing global industry.